News from NORD

FDA Commissioner to Present Keynote Address at NORD Summit


 

Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, will present the keynote address in the opening session of the 2017 NORD Summit. Dr. Gottlieb, who was sworn in as FDA Commissioner in May 2017, previously served as FDA’s Deputy Commissioner for Medical and Scientific Affairs. Before that, he was Senior Adviser to the FDA Commissioner.

Mike Porath, award-winning journalist and founder/CEO of The Mighty, will present the patient keynote. He has held writing, editing, and executive positions at ABC News, NBC News, the New York Times, and AOL. Mr. Porath is the father of a child with Dup15q syndrome and sits on the board of Dup15q Alliance.

Recommended Reading

Platelet Disorder Support Association to Present Annual ITP Update
MDedge Hematology and Oncology
Pulmonary Hypertension Association and ATS to Host PH Program
MDedge Hematology and Oncology
Registration Is Open for Spinal CSF Leak Foundation Symposium
MDedge Hematology and Oncology
Rare Neuro-Immune Disorders Symposium Is Planned
MDedge Hematology and Oncology
CDC Offers Free Webinar on Bleeding Disorders in Women and Girls
MDedge Hematology and Oncology
FDA approves Rebinyn for hemophilia B treatment
MDedge Hematology and Oncology
TRK inhibitor shows ‘striking’ activity, durability across diverse adult and pediatric cancers
MDedge Hematology and Oncology
Blood markers can detect early pancreatic cancer
MDedge Hematology and Oncology
Bone marrow transplantation for epidermolysis bullosa continues to evolve
MDedge Hematology and Oncology
Preview Agenda for NORD’s 2017 Rare Diseases and Orphan Products
MDedge Hematology and Oncology